Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria

Schmitt, Esther K.; Ndayisaba, Gilles; Yeka, Adoke; Asante, Kwaku Poku; Grobusch, Martin P.; Karita, Etienne; Mugerwa, Henry; Asiimwe, Stephen; Oduro, Abraham; Fofana, Bakary; Doumbia, Seydou; Su, Guoqin; Renner, Katalin Csermak; Venishetty, Vinay Kumar; Sayyed, Sarfaraz; Straimer, Judith; Demin, Ivan; Barsainya, Sarita; Boulton, Caroline; Gandhi, Preetam

Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria

Autor(en):

Schmitt, Esther K.; Ndayisaba, Gilles; Yeka, Adoke; Asante, Kwaku Poku; Grobusch, Martin P.; Karita, Etienne; Mugerwa, Henry; Asiimwe, Stephen; Oduro, Abraham; Fofana, Bakary; Doumbia, Seydou; Su, Guoqin; Renner, Katalin Csermak; Venishetty, Vinay Kumar; Sayyed, Sarfaraz; Straimer, Judith; Demin, Ivan; Barsainya, Sarita; Boulton, Caroline; Gandhi, Preetam

Tübinger Autor(en):

Grobusch, Martin

Erschienen in:

Clinical Infectious Diseases (2022), Bd. 74, H. 10, S. 1831-1839

Verlagsangabe:

Oxford Univ Press Inc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1093/cid/ciab716

ISSN:

1058-4838